Research programme: potassium channel activators - Soleno Therapeutics/Vanderbilt University
Alternative Names: ATP-dependent potassium channel activators - Soleno Therapeutics/Vanderbilt University; ATP-sensitive potassium (K) channel activators - Soleno Therapeutics/Vanderbilt University; K(ATP) Channel Activators - Soleno Therapeutics/Vanderbilt University; KATP channel activators - Soleno Therapeutics/Vanderbilt UniversityLatest Information Update: 21 Apr 2021
At a glance
- Originator Soleno Therapeutics; Vanderbilt University
- Class Antihypoglycaemics; Obesity therapies
- Mechanism of Action KATP channel stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Hypoglycaemia; Prader-Willi syndrome